Current intravesical therapies BCG-failure in non-muscle-invasive bladder cancer
The first-line treatment for non-muscle invasive bladder cancer (NMIBC) is intravesical Bacillus CalmetteGuerin (BCG). Despite BCG, alternative treatments are urgently required for recurrent or progressive bladder cancer. Cystectomy is the gold standard treatment in BCG failure in bladder cancer. Wh...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ali İhsan Taşçı
2021-10-01
|
Series: | Yeni Üroloji Dergisi |
Online Access: | https://dergipark.org.tr/tr/pub/yud/issue/64959/913785 |